
sharpely
@sharpely_in
Followers
5K
Following
9K
Media
2K
Statuses
3K
Investment Research Platform | SEBI registered RA: INH000009524 | All Tweets are Data-driven Opinions. We help you make the right investment decisions.
Thane, Maharashtra
Joined February 2023
Markets near all-time highs. Our prices at an all-time low. It can’t get any better than this. 💡 Use Code: DIWALI15
0
1
2
Till now, 125 companies have announced their Q2 results. Median topline growth 12.89% YoY Median bottom-line growth 17.88% YoY. A good start to the Q2 result season. But the picture will become clearer in the next three weeks! Source: https://t.co/GJaBlxeJAU
#Q2Results
0
0
3
It is also a name that fits well in Richard Driehaus's Momentum Strategy!
0
0
0
#Privi Clean breakout on charts. The company operates in aroma chemicals and specialty chemicals. Q1 numbers were good as well. #StockToWatch #StockMarket
2
0
4
#HDFCAMC Solid #Q2Results from the company. Net profit up 24.6% YoY at ₹718.4 cr vs ₹576.4 cr Revenue up 15.8% YoY at ₹1,027.4 cr vs ₹887.2 cr Also announced a 1:1 bonus issue!
0
0
2
Useful data points!
Indian Pharma players September and Q2Fy26 export performance - MoM winners (Sep’25) - Ami Organics +468%, JB Chem +226%, Blue Jet +134%, Natco +119%, Solara +103%, Neuland +94%, Cipla +59%, Divi’s +24% YoY (Sep’25 vs Sep’24) leaders: Sequent Scientific +287%, JB Chem +62%,
0
0
2
Some important #Q2Results to track today! HDB Financial Services HDFC Asset Management Company HDFC Life Insurance Company KEI Industries Axis Bank L&T Finance Angel One Oberoi Realty Tata Communications Source: https://t.co/kuu8sJO4KS
#Q2FY26
sharpely.in
A comprehensive calendar of upcoming events and activities on Sharpely. Stay updated with the latest happenings and plan your schedule effortlessly. Don't miss out – latest stock events today!
0
0
1
Thyrocare Technologies (#Thyrocare) A stellar Q2FY26 from Thyrocare as the company delivered its best-ever performance across key financial metrics. 🚀 Revenue climbed 22% YoY to ₹217 cr (vs ₹177 cr), with Q1 at ₹193 cr. PBT surged to ₹62 cr (vs ₹37 cr YoY, ₹50 cr in
0
0
2
A weak day for the market. 75% of the Nifty 500 stocks ended the day in the red today. #StockMarketIndia
0
2
4
After TCS, Adani Group joins the AI data centre race, partnering with Google to strengthen India’s AI infrastructure ecosystem. It seems like more and more companies with deep pockets will join this bandwagon. Indirect beneficiaries could be solar companies, as these data
A monumental day for India! Adani is proud to partner with @Google to build India’s largest AI data centre campus - in Visakhapatnam - engineered specifically for the demands of artificial intelligence. This facility will house the TPU and GPU-based compute power required for
0
1
3
IREDA (#IREDA) Strong operational performance in Q2FY26 with good growth across key profitability metrics. Revenue: ₹2,057 cr vs ₹1,630 cr YoY (₹1,959 cr in Q1) PBT: ₹696 cr vs ₹460 cr YoY (₹305 cr in Q1) PAT: ₹549 cr vs ₹398 cr YoY (₹247 cr in Q1) Impairments: Lower
0
0
6
Pure madness in Silver ETFs now. Low volume + High euphoric demand + Physical shortage Most of them are trading at a big premium. #silversqueeze #Silver
1
1
9
Here’s something worth noting 👇 ABSL AMC and UTI AMC trade at a discount to HDFC AMC and NAM India. Why? The answer is in the growth rates. Look at the 2nd and 3rd rows on the right table. The numbers reveal the whole picture. PS: Not a reco.
0
0
1
4) UTI AMC: 4.56%🔼 A solid bounce from the 21-day EMA with good volume.
1
0
1
3) ABSL AMC: 4.46%🔼 Strong bounce from 21-day EMA with very high volume!
1
0
0
2) NAM Life India AMC: 1.41%🔼 and trading near the ATH resistance zone.
1
0
0
AMC stocks were on the move today. 1) HDFC AMC: 2.7%🔼 The price is now above the key 21-day EMA! #StocksToWatch #StockMarketUpdate #StocksInFocus
1
0
1
Stallion India Fluorochemicals (#StallionFluoro #Stallion) Strong Q2FY26 performance with visible margin expansion YoY and a healthy QoQ improvement. While Q2 is typically the leanest quarter for the company, this time it has delivered solid numbers: Revenue: ₹105 cr vs ₹68
0
1
9